Cargando…

Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis

BACKGROUND: Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yetmar, Zachary A, Chesdachai, Supavit, Kashour, Tarek, Riaz, Muhammad, Gerberi, Danielle J, Badley, Andrew D, Berbari, Elie F, Tleyjeh, Imad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244756/ https://www.ncbi.nlm.nih.gov/pubmed/34258316 http://dx.doi.org/10.1093/ofid/ofab284

Ejemplares similares

Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Kashour, Zakariya, et al.
Publicado: (2021)

Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician
por: Tleyjeh, Imad M, et al.
Publicado: (2021)

The Characteristics of Capnocytophaga Infection: 10 Years of Experience
por: Chesdachai, Supavit, et al.
Publicado: (2021)

Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection
por: Yetmar, Zachary A, et al.
Publicado: (2023)

Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis
por: Alkodaymi, Mohamad Salim, et al.
Publicado: (2022)

Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19
por: Yetmar, Zachary A., et al.
Publicado: (2021)

Which are the best coronavirus disease 2019 vaccines?
por: Omrani, Ali S., et al.
Publicado: (2021)

It is time to drop hydroxychloroquine from our COVID-19 armamentarium
por: Kashour, Tarek, et al.
Publicado: (2020)

Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021)

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
por: Tande, Aaron J, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
por: Virk, Abinash, et al.
Publicado: (2023)

A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study
por: Sendi, Parham, et al.
Publicado: (2021)

Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2020)

Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease
por: Florêncio, Francisco Kleyton Zacarias, et al.
Publicado: (2020)

Utility of Metagenomic Next-Generation Sequencing in Infective Endocarditis: A Systematic Review
por: Haddad, Sara F., et al.
Publicado: (2022)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Incidence and Outcomes of Bloodstream Infection After Arterial Aneurysm Repair: Findings From a Population-Based Study
por: Tabaja, Hussam, et al.
Publicado: (2023)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

Antifungal Susceptibility Pattern of Candida glabrata from a Referral Center and Reference Laboratory: 2012–2022
por: Chesdachai, Supavit, et al.
Publicado: (2023)

1779. Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data and Outcomes
por: Katragadda, Silpita, et al.
Publicado: (2023)

243. A Laboratory Intervention to Enhance Recognition of Bacteremia in Patients with Staphylococcus aureus Bacteriuria
por: Vaillant, James J, et al.
Publicado: (2023)

Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More
por: Joshi, Seema, et al.
Publicado: (2021)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study
por: Richardson, Safiya, et al.
Publicado: (2021)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
por: Ramakrishnan, Rakhee K., et al.
Publicado: (2021)

Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China
por: Cheng, Biheng, et al.
Publicado: (2020)

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia
por: Chesdachai, Supavit, et al.
Publicado: (2022)

Candidemia in Patients With Cardiovascular Implantable Electronic Devices: Uncertainty in Management Based on Current International Guidelines
por: Chesdachai, Supavit, et al.
Publicado: (2023)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2b5i8he2b7ok9p7vhg3ce3h14k